The trademark application NEULASTIM was filed by Amgen Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 1, 2001, and it was registered by office on May 2, 2002 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Two renewals of the trademark were recorded, one on March 10, 2011, and the other one on February 24, 2021.
Change of name and address of the trademark registration was recorded on August 13, 2007. Change of name and professional address of the trademark registration was recorded on August 13, 2007. Change of name and address of the trademark registration was recorded on September 17, 2007. Change of name and address of the trademark registration was recorded on March 17, 2008. Change of name and professional address of the trademark registration was recorded on March 18, 2011. Change of name and professional address of the trademark registration was recorded on April 4, 2013. Change of name and professional address of the trademark registration was recorded on September 29, 2015. Appointment and Replacement of representative of the trademark registration was recorded on June 1, 2021.